Enfortumab vedotin with or without pembrolizumab offers disease control benefits for patients with upper tract urothelial cancer, said Evangelia Vlachou, MD, of Johns Hopkins Medicine.
A life sciences firm has received £100,000 backing. CCI Photonics has been supported by LYVA Labs to develop a urinary tract… ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback